• Nov 17, 2025 a glimpse of the potential of crispr cas9 for tre RISPR-Cas9 in enhancing TCR therapies for solid tumors? The technology holds potential for overcoming tumor microenvironment barriers, improving T-cell infiltration, and customizing TCRs to target a broader By Vena Feest
